On Tuesday shares of Vodafone Group Plc (ADR) (NASDAQ:VOD) closed at $36.47. Company’s sales growth for last 5 years was -1.30%. Vodafone Group Plc (ADR) (NASDAQ:VOD)‘s stock had its “accumulate” rating reaffirmed by investment analysts at Banca Akros in a note issued to investors on Tuesday. They currently have a GBX 240 ($3.71) price target on the stock.
Fate Therapeutics, Inc. (NASDAQ:FATE) in last trading activity fell -0.27% to close at $7.34. Company weekly performance is 47.98% while its quarterly performance stands at 52.92%. Fate Therapeutics, Inc. (NASDAQ:FATE) is -16.40% away from its 52 week high. On May 7, Fate Therapeutics, Inc. (Nasdaq:FATE), announced its financial results for the first quarter ended March 31, 2015. Cash and cash equivalents as of March 31, 2015 were $42.3 million, compared to $49.1 million as of December 31, 2014. The decrease is primarily driven by the Company’s use of cash to fund operating activities of $6.4 million during the first quarter of 2015.
On last trading day Hyster-Yale Materials Handling, Inc. (NYSE:HY) advanced 0.08% to close at $73.86. Its volatility for the week is 2.25% while volatility for the month is 2.65%. HY’s sales growth for past 5 years was 13.40% and its EPS growth for past 5 years was 35.30%. Hyster-Yale Materials Handling, Inc. (NYSE:HY) monthly performance is -1.01%. Hyster-Yale Materials Handling, Inc. (NYSE:HY) announced that the Board of Directors increased its regular cash dividend from 27.50 cents to 28.50 cents per share. The dividend is payable on both the Class A and Class B Common Stock, and will be paid June 16, 2015 to stockholders of record at the close of business on June 1, 2015. The new dividend is equal to an annual rate of $1.14 per share.
Theravance Biopharma, Inc. (NASDAQ:TBPH) has 6.00% insider ownership while its institutional ownership stands at 63.80%. In last trading activity company’s stock closed at $14.50. On May 7, Theravance Biopharma Inc. (NASDAQ:TBPH) reported a loss of $42.5 million in its first quarter. On a per-share basis, the George Town Grand Cayman, Cayman Islands-based company said it had a loss of $1.29. The biopharmaceutical company posted revenue of $20.4 million in the period.
On last trading day Furmanite Corporation (NYSE:FRM) advanced 2.66% to close at $8.89. Its volatility for the week is 5.34% while volatility for the month is 4.62%. FRM’s sales growth for past 5 years was 13.90% and its EPS growth for past 5 years was 41.90%. Furmanite Corporation (NYSE:FRM) monthly performance is 11.40%. Furmanite Corporation (NYSE:FRM) reported results for the quarter ended March 31, 2015. Revenues for the three months ended March 31, 2015 were $122.3 million, a decrease of $2.6 million, or 2.1%, from the $124.9 million reported for the three months ended March 31, 2014.